Kenneth H. Grabstein
About
In The Last Decade
Kenneth H. Grabstein
86 papers receiving 15.2k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Immunology 11.6k
- Oncology 3.2k
- Epidemiology 2.8k
- Molecular Biology 2.6k
- Radiology, Nuclear Medicine and Imaging 1.1k
Countries citing papers authored by Kenneth H. Grabstein
This map shows the geographic impact of Kenneth H. Grabstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth H. Grabstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth H. Grabstein more than expected).
Fields of papers citing papers by Kenneth H. Grabstein
This network shows the impact of papers produced by Kenneth H. Grabstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth H. Grabstein. The network helps show where Kenneth H. Grabstein may publish in the future.
Co-authorship network of co-authors of Kenneth H. Grabstein
This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth H. Grabstein. A scholar is included among the top collaborators of Kenneth H. Grabstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth H. Grabstein. Kenneth H. Grabstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects breakdown → | 1040 |
| 3 | 5 | |
| 4 | 27 | |
| 5 | 8 | |
| 6 | Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer. | 119 |
| 7 | 83 | |
| 8 | 131 | |
| 9 | Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients. | 44 |
| 10 | 30 | |
| 11 | 288 | |
| 12 | 138 | |
| 13 | Molecular and biological characterization of a murine ligand for CD40 breakdown → | 875 |
| 14 | 14 | |
| 15 | 363 | |
| 16 | 5 | |
| 17 | 190 | |
| 18 | 5 | |
| 19 | 120 | |
| 20 | 161 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.